On the one hand, ATF4 can drive sorafenib resistance in HCC by inhibiting ferroptosis [81]; on the other hand, sevoflurane has been shown to induce ferroptosis of glioma cells through ATF4 activation [82]. The gene discussed is ATF4; the disease is hepatocellular carcinoma.